Conjugation of brain-derived neurotrophic factor to a blood–brain barrier drug targeting system enables neuroprotection in regional brain ischemia following intravenous injection of the neurotrophin
- 1 January 2001
- journal article
- Published by Elsevier in Brain Research
- Vol. 889 (1-2) , 49-56
- https://doi.org/10.1016/s0006-8993(00)03108-5
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Ischemic Brain Damage in Mice after Selectively Modifying BDNF or NT4 Gene ExpressionJournal of Cerebral Blood Flow & Metabolism, 2000
- Reduction of Ischemic Damage by Application of Vascular Endothelial Growth Factor in Rat Brain after Transient IschemiaJournal of Cerebral Blood Flow & Metabolism, 1998
- Epidermal Growth Factor Protects Neuronal Cells In Vivo and In Vitro against Transient Forebrain Ischemia- and Free Radical-Induced InjuriesJournal of Cerebral Blood Flow & Metabolism, 1998
- Drug Delivery to the BrainJournal of Cerebral Blood Flow & Metabolism, 1997
- Distribution of Brain‐Derived Neurotrophic Factor in Rats and Its Changes with Development in the BrainJournal of Neurochemistry, 1997
- PHARMACOLOGY OF NEUROTROPHIC FACTORSAnnual Review of Pharmacology and Toxicology, 1997
- Disruption of the low affinity receptor-binding site in NGF allows neuronal survival and differentiation by binding to the trk gene productCell, 1992
- A Semiautomated Method for Measuring Brain Infarct VolumeJournal of Cerebral Blood Flow & Metabolism, 1990
- Reversible middle cerebral artery occlusion without craniectomy in rats.Stroke, 1989
- Receptor Binding Activities of Biotinylated Derivatives of β‐Nerve Growth FactorJournal of Neurochemistry, 1986